Title | THINK INK |
Brand | IMMUNOCORE |
Product/Service | N/A |
Category |
E02. Dierct to Healthcare Professional |
Entrant
|
SYNEOS HEALTH London, UNITED KINGDOM
|
Idea Creation
|
SYNEOS HEALTH London, UNITED KINGDOM
|
Production
|
EMBER FILMS Wymondham, UNITED KINGDOM
|
Additional Company
|
NAVICOR, A SYNEOS HEALTH COMPANY Westerville, USA
|
Credits
Sinéad Murphy |
Syneos Health Communications |
Creative Director |
Rich D’Ginto |
Navicor, a Syneos Health® company |
Executive Creative Director |
Andrew Musumeci |
Syneos Health Communications |
Art Director |
John Kirk |
Navicor, a Syneos Health® company |
Art Director |
Russell Speed |
Syneos Health Communications |
Creative Copywriter |
Liana Federico |
Syneos Health Communications |
Deputy Managing Director |
Michael Krohn |
Navicor, a Syneos Health® company |
VP Account Director |
Beth Collen |
Navicor, a Syneos Health® company |
Account Director |
Rebecca Bull |
Syneos Health Communications |
Junior Account Director |
Jonathan Jones |
Ember Films |
Director |
Simon Buck |
Ember Films |
Photographer |
Shahin Tossi |
Ember Films |
Digital Artist |
Max Böhlen |
Ember Films |
Digital Artist |
Describe any restrictions or regulations regarding Healthcare/RX/Pharma communications in your country/region including:
Disease Awareness communication is defined by the FDA as those “that discuss a particular disease or health condition, but does not mention any specific drug and does not make any representation or suggestion concerning a particular drug”.
Describe the target audience and why your work is relevant to them.
Aimed at optometrists, ophthalmologists and oncologists to raise awareness of Uveal Melanoma – a rare and often overlooked cancer which starts in the eye, and can be fatal within 12 months. Something specific and memorable was needed to ensure recognition of a case and the need to take immediate action.
Write a short summary of what happens in the film
Think Ink is an external visualisation of a disease that starts in the eye and spreads through the circulatory system to the liver. Survival is only 12 months once Uveal Melanoma is in the liver, so it needs to be spotted early.
An initial ink drop spreads down the face and across the body – paced to create a tense, dramatic film without it falling into mock horror.
As the film develops, the volume of ink and the speed of runs ramps up across the body.
Cuts to isolated areas maintains the suspense and prevents the visual punchline being delivered too quickly.
The final camera pull reveal shows a man consumed by disease and emotional resignation etched on his face.
The film ends with a bespoke blinking logo designed specifically for the campaign. This is an essential diagnostic indicator for the target audience.